The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma

References

• Rouhani P, Fletcher CD, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer. 2008;113(3):616–627. doi:10.1002/cncr.2357118618615
   PubMed Web of Science ®Google Scholar
• Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922–2930. doi:10.1002/ijc.2223917013893
   PubMed Web of Science ®Google Scholar
• Wang L, Lao IW, Yu L, Wang J. Clinicopathological features and prognostic factors in angiosarcoma: a retrospective analysis of 200 patients from a single Chinese medical institute. Oncol Lett. 2017;14(5):5370–5378. doi:10.3892/ol.2017.689229113171
   PubMed Web of Science ®Google Scholar
• Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18(12):2030–2036.17974557
   PubMed Web of Science ®Google Scholar
• Shin JY, Roh SG, Lee NH, Yang KM. Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis. Head Neck. 2017;39(2):380–386.27507124
   PubMed Web of Science ®Google Scholar
• Kunkiel M, Maczkiewicz M, Jagiello-Gruszfeld A, Nowecki Z. Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience. Curr Oncol. 2018;25(1):e50–e53.29507495
   PubMed Web of Science ®Google Scholar
• Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11(3):241–247.16053668
   PubMed Web of Science ®Google Scholar
• Botti G, Scognamiglio G, Marra L, et al. Programmed death ligand 1 (PD-L1) expression in primary angiosarcoma. J Cancer. 2017;8(16):3166–3172.29158788
   PubMed Web of Science ®Google Scholar
• Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61(3):170–176.8637202
   PubMed Web of Science ®Google Scholar
• Buschmann A, Lehnhardt M, Toman N, Preiler P, Salakdeh MS, Muehlberger T. Surgical treatment of angiosarcoma of the scalp: less is more. Ann Plast Surg. 2008;61(4):399–403. doi:10.1097/SAP.0b013e31816b31f818812710
   PubMed Web of Science ®Google Scholar
• Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77(11):2400–2406. doi:10.1002/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z8635113
   PubMed Web of Science ®Google Scholar
• Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer. 1981;48(8):1907–1921. doi:10.1002/1097-0142(19811015)48:8<1907::aid-cncr2820480832>3.0.co;2-t7197190
   PubMed Web of Science ®Google Scholar
• Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59(5):1046–1057. doi:10.1002/1097-0142(19870301)59:5<1046::aid-cncr2820590533>3.0.co;2-63815265
   PubMed Web of Science ®Google Scholar
• Ito T, Tanaka K, Suzumura K, et al. Angiosarcoma arising in the non-operated, sclerosing breast after primary irradiation, surviving 6 years post-resection: a case report and review of the Japanese literature. Int J Surg Case Rep. 2016;24:26–31. doi:10.1016/j.ijscr.2016.05.00127179333
   PubMedGoogle Scholar
• Nomura M, Nakaya Y, Saito K, et al. Hemopneumothorax secondary to multiple cavitary metastasis in angiosarcoma of the scalp. Respiration. 1994;61(2):109–112. doi:10.1159/0001963188008986
   PubMed Web of Science ®Google Scholar
• Yonemori K, Tsuta K, Ando M, et al. Contrasting prognostic implications of platelet-derived growth factor receptor-beta and vascular endothelial growth factor receptor-2 in patients with angiosarcoma. Ann Surg Oncol. 2011;18(10):2841–2850. doi:10.1245/s10434-011-1640-421409488
   PubMed Web of Science ®Google Scholar
• Choi ES, Kim HS, Han I. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Ann Surg Oncol. 2014;21(3):778–785. doi:10.1245/s10434-013-3418-324306668
   PubMed Web of Science ®Google Scholar
• Que Y, Qiu H, Li Y, et al. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma. BMC Cancer. 2015;15:648. doi:10.1186/s12885-015-1584-326432433
   PubMed Web of Science ®Google Scholar
• Szkandera J, Gerger A, Liegl-Atzwanger B, et al. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2014;135(2):362–370. doi:10.1002/ijc.2867724347236
   PubMed Web of Science ®Google Scholar
• Suzuki G, Yamazaki H, Aibe N, et al. Clinical usefulness of the platelet-to lymphocyte ratio in patients with angiosarcoma of the face and scalp. Int J Mol Sci. 2017;18(11). doi:10.3390/ijms18112402
   Web of Science ®Google Scholar
• Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11(10):983–991. doi:10.1016/S1470-2045(10)70023-120537949
   PubMed Web of Science ®Google Scholar
• Biswas B, Dabkara D. Bevacizumab in advanced angiosarcoma: what is the reality? J Clin Oncol. 2016;34(7):764. doi:10.1200/JCO.2015.64.2181
   PubMed Web of Science ®Google Scholar
• Italiano A, Chen CL, Thomas R, et al. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer. 2012;118(23):5878–5887. doi:10.1002/cncr.2761422648906
   PubMed Web of Science ®Google Scholar
• Letsa I, Benson C, Al-Muderis O, Judson I. Angiosarcoma of the face and scalp: effective systemic treatment in the older patient. J Geriatr Oncol. 2014;5(3):276–280. doi:10.1016/j.jgo.2014.02.00424685486
   PubMed Web of Science ®Google Scholar
• Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute. World J Surg. 2011;35(11):2417–2421. doi:10.1007/s00268-011-1225-121882024
   PubMed Web of Science ®Google Scholar
• Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22(6):683–697.9630175
   PubMed Web of Science ®Google Scholar
• Zheng YW, Zhang XW, Zhang JL, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol. 2014;29(5):906–911. doi:10.1111/jgh.1250624372769
   PubMed Web of Science ®Google Scholar
• Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast. Cancer. 2005;104(12):2682–2688. doi:10.1002/cncr.2153116288486
   PubMed Web of Science ®Google Scholar
• Hodgson NC, Bowen-Wells C, Moffat F, Franceschi D, Avisar E. Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol. 2007;30(6):570–573. doi:10.1097/COC.0b013e3181131d6218091049
   PubMed Web of Science ®Google Scholar
• Nascimento AF, Raut CP, Fletcher CD. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 2008;32(12):1896–1904. doi:10.1097/PAS.0b013e318176dbc718813119
   PubMed Web of Science ®Google Scholar
• Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14(6):1953–1967. doi:10.1245/s10434-006-9335-y17356953
   PubMed Web of Science ®Google Scholar
• Lahat G, Dhuka AR, Lahat S, et al. Outcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol. 2009;16(9):2502–2509. doi:10.1245/s10434-009-0569-319551444
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Paulino AF, McGinn CJ, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003;98(8):1716–1726. doi:10.1002/cncr.1166714534889
   PubMed Web of Science ®Google Scholar
• Sher T, Hennessy BT, Valero V, et al. Primary angiosarcomas of the breast. Cancer. 2007;110(1):173–178. doi:10.1002/cncr.2278417541936
   PubMed Web of Science ®Google Scholar
• Karpeh MS Jr., Caldwell C, Gaynor JJ, Hajdu SI, Brennan MF. Vascular soft-tissue sarcomas. An analysis of tumor-related mortality. Arch Surg. 1991;126(12):1474–1481. doi:10.1001/archsurg.1991.014103600440081842176
   PubMedGoogle Scholar
• Krishnamoorthy RV, Reddy VV. Hepatopancreatic amylase activity as a function of warm-adaptation in a fresh-water field crab. Experientia. 1968;24(10):1019–1020. doi:10.1007/bf021387205711862
   PubMedGoogle Scholar
• Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971–978. doi:10.1016/j.ctrv.2015.10.00326481060
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Journal of the National Cancer Institute. 2014;106(6):dju124. doi:10.1093/jnci/dju06124875653
   PubMedGoogle Scholar
• Kano S, Homma A, Hatakeyama H, et al. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck. 2017;39(2):247–253. doi:10.1002/hed.2457627617428
   PubMed Web of Science ®Google Scholar
• Piciucchi M, Stigliano S, Archibugi L, et al. The neutrophil/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients. Int J Mol Sci. 2017;18(4):730.
   PubMed Web of Science ®Google Scholar
• Luo H, Ge H, Cui Y, et al. Systemic inflammation biomarkers predict survival in patients of early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy - a single center experience. J Cancer. 2018;9(1):182–188.29290784
   PubMed Web of Science ®Google Scholar
• Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994;219(4):325–331.7512810
   PubMed Web of Science ®Google Scholar
• Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29(5):3092–3100.22476808
   PubMed Web of Science ®Google Scholar
• Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3–4):215–220.18424885
   PubMed Web of Science ®Google Scholar
• Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(2):425–428.19185164
   PubMed Web of Science ®Google Scholar
• Mando P, Rizzo M, Roberti MP, et al. High neutrophil to lymphocyte ratio and decreased CD69(+)NK cells represent a phenotype of high risk in early-stage breast cancer patients. Onco Targets Ther. 2018;11:2901–2910.29844687
   PubMed Web of Science ®Google Scholar
• Fujisawa Y, Yoshino K, Fujimura T, et al. Cutaneous angiosarcoma: the possibility of new treatment options especially for patients with large primary tumor. Frontiers in Oncology. 2018;8:46.29552543
   PubMed Web of Science ®Google Scholar